SIRION BIOTECH specialises in viral vector platforms and provides sophisticated cell modelling, which enables a highly improved target identification and compound screening in the drug, food and cosmetic industries
The technology leader in the field of functional gene analysis and cell models for early research has built a sophisticated technology platform consisting of:
SIRION BIOTECH offers Cells by Design™ that come as:
SIRION BIOTECH’S specialisation in this field allows for greater chances of success with primary cell immortalisations. Only with such specialization is it possible to construct adenovirus serotype vectors which may serve as the basis for novel future vaccines with improved immunity.
Multiple ways exist to work with SIRION BIOTECH ranging from
Founded in 2006 by scientists from Munich University (LMU) the idea behind SIRION BIOTECH was to change the paradigm of in vitro cell modelling for more effective target & compound research. Since then, SIRION BIOTECH has been filing several patent applications and has been refining its technical competence in hundreds of client projects. Clients and Alliance Partners range from across Europe, Japan and the U.S.